Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Budinská E[au]:

Search results

Items: 46

1.

Administration of the Probiotic Escherichia coli Strain A0 34/86 Resulted in a Stable Colonization of the Human Intestine During the First Year of Life.

Micenková L, Bosák J, Smatana S, Novotný A, Budinská E, Šmajs D.

Probiotics Antimicrob Proteins. 2019 May 8. doi: 10.1007/s12602-019-09548-3. [Epub ahead of print]

PMID:
31069717
2.

Microbiome and Metabolome Profiles Associated With Different Types of Short Bowel Syndrome: Implications for Treatment.

Budinska E, Gojda J, Heczkova M, Bratova M, Dankova H, Wohl P, Bastova H, Lanska V, Kostovcik M, Dastych M, Senkyrik M, Krizova J, Mraz M, Hradecky J, Hajslova J, Lenicek M, Podzimkova K, Chalupsky K, Sedlacek R, Cahova M.

JPEN J Parenter Enteral Nutr. 2019 Apr 29. doi: 10.1002/jpen.1595. [Epub ahead of print]

PMID:
31032975
3.

Porcine pathogenic Escherichia coli strains differ from human fecal strains in occurrence of bacteriocin types.

Bosák J, Hrala M, Pirková V, Micenková L, Čížek A, Smola J, Kučerová D, Vacková Z, Budinská E, Koláčková I, Šmajs D.

Vet Microbiol. 2019 May;232:121-127. doi: 10.1016/j.vetmic.2019.04.003. Epub 2019 Apr 6.

PMID:
31030835
4.

Dynamics of allergy development during the first 5 years of life.

Vrbova M, Dorociakova P, Vyskovsky R, Palkovicova Murinova L, Ciznar P, Rausova K, McNabb SJN, Reichrtova E, Budinska E, Thon V.

Eur J Pediatr. 2018 Sep;177(9):1317-1325. doi: 10.1007/s00431-018-3188-9. Epub 2018 Jun 22.

PMID:
29934773
5.

A critical comparison of topology-based pathway analysis methods.

Ihnatova I, Popovici V, Budinska E.

PLoS One. 2018 Jan 25;13(1):e0191154. doi: 10.1371/journal.pone.0191154. eCollection 2018.

6.

Interrogating open issues in cancer medicine with patient-derived xenografts.

Byrne AT, Alférez DG, Amant F, Annibali D, Arribas J, Biankin AV, Bruna A, Budinská E, Caldas C, Chang DK, Clarke RB, Clevers H, Coukos G, Dangles-Marie V, Eckhardt SG, Gonzalez-Suarez E, Hermans E, Hidalgo M, Jarzabek MA, de Jong S, Jonkers J, Kemper K, Lanfrancone L, Mælandsmo GM, Marangoni E, Marine JC, Medico E, Norum JH, Palmer HG, Peeper DS, Pelicci PG, Piris-Gimenez A, Roman-Roman S, Rueda OM, Seoane J, Serra V, Soucek L, Vanhecke D, Villanueva A, Vinolo E, Bertotti A, Trusolino L.

Nat Rev Cancer. 2017 Sep 15;17(10):632. doi: 10.1038/nrc.2017.85. [Epub ahead of print]

PMID:
28912576
7.

Identification of "BRAF-Positive" Cases Based on Whole-Slide Image Analysis.

Popovici V, Křenek A, Budinská E.

Biomed Res Int. 2017;2017:3926498. doi: 10.1155/2017/3926498. Epub 2017 Apr 24.

8.

Dirigent proteins in plants: modulating cell wall metabolism during abiotic and biotic stress exposure.

Paniagua C, Bilkova A, Jackson P, Dabravolski S, Riber W, Didi V, Houser J, Gigli-Bisceglia N, Wimmerova M, Budínská E, Hamann T, Hejatko J.

J Exp Bot. 2017 Jun 15;68(13):3287-3301. doi: 10.1093/jxb/erx141. Review.

PMID:
28472349
9.

[Circulating Myeloid Suppressor Cells and Their Role in Tumour Immunology].

Pilatova K, Budinská E, Bensciková B, Nenutil R, Šefr R, Fedorová L, Hanáková B, Brychtová V, Zdražilová Dubská L.

Klin Onkol. Spring 2017;30(Supplementum1):166-169. Czech.

PMID:
28471197
10.

[Molecular Pathology of Colorectal Cancer, Microsatellite Instability - the Detection, the Relationship to the Pathophysiology and Prognosis].

Brychtová V, Šefr R, Hrstka R, Vídeňská P, Bencsiková B, Hanáková B, Zdražilová Dubská L, Nenutil R, Budinská E.

Klin Onkol. Spring 2017;30(Supplementum1):153-155. Czech.

PMID:
28471193
11.

Image-based surrogate biomarkers for molecular subtypes of colorectal cancer.

Popovici V, Budinská E, Dušek L, Kozubek M, Bosman F.

Bioinformatics. 2017 Jul 1;33(13):2002-2009. doi: 10.1093/bioinformatics/btx027.

PMID:
28158480
12.

Interrogating open issues in cancer precision medicine with patient-derived xenografts.

Byrne AT, Alférez DG, Amant F, Annibali D, Arribas J, Biankin AV, Bruna A, Budinská E, Caldas C, Chang DK, Clarke RB, Clevers H, Coukos G, Dangles-Marie V, Eckhardt SG, Gonzalez-Suarez E, Hermans E, Hidalgo M, Jarzabek MA, de Jong S, Jonkers J, Kemper K, Lanfrancone L, Mælandsmo GM, Marangoni E, Marine JC, Medico E, Norum JH, Palmer HG, Peeper DS, Pelicci PG, Piris-Gimenez A, Roman-Roman S, Rueda OM, Seoane J, Serra V, Soucek L, Vanhecke D, Villanueva A, Vinolo E, Bertotti A, Trusolino L.

Nat Rev Cancer. 2017 Apr;17(4):254-268. doi: 10.1038/nrc.2016.140. Epub 2017 Jan 20. Review. Erratum in: Nat Rev Cancer. 2017 Sep 15;:.

13.

Joint analysis of histopathology image features and gene expression in breast cancer.

Popovici V, Budinská E, Čápková L, Schwarz D, Dušek L, Feit J, Jaggi R.

BMC Bioinformatics. 2016 May 11;17(1):209. doi: 10.1186/s12859-016-1072-z.

14.

DNA Topoisomerase I Gene Copy Number and mRNA Expression Assessed as Predictive Biomarkers for Adjuvant Irinotecan in Stage II/III Colon Cancer.

Nygård SB, Vainer B, Nielsen SL, Bosman F, Tejpar S, Roth A, Delorenzi M, Brünner N, Budinska E.

Clin Cancer Res. 2016 Apr 1;22(7):1621-31. doi: 10.1158/1078-0432.CCR-15-0561. Epub 2015 Nov 5.

15.

ToPASeq: an R package for topology-based pathway analysis of microarray and RNA-Seq data.

Ihnatova I, Budinska E.

BMC Bioinformatics. 2015 Oct 29;16:350. doi: 10.1186/s12859-015-0763-1.

16.

TopKLists: a comprehensive R package for statistical inference, stochastic aggregation, and visualization of multiple omics ranked lists.

Schimek MG, Budinská E, Kugler KG, Švendová V, Ding J, Lin S.

Stat Appl Genet Mol Biol. 2015 Jun;14(3):311-6. doi: 10.1515/sagmb-2014-0093.

PMID:
25968440
17.

Combined Proteomics and Transcriptomics Identifies Carboxypeptidase B1 and Nuclear Factor κB (NF-κB) Associated Proteins as Putative Biomarkers of Metastasis in Low Grade Breast Cancer.

Bouchal P, Dvořáková M, Roumeliotis T, Bortlíček Z, Ihnatová I, Procházková I, Ho JT, Maryáš J, Imrichová H, Budinská E, Vyzula R, Garbis SD, Vojtěšek B, Nenutil R.

Mol Cell Proteomics. 2015 Jul;14(7):1814-30. doi: 10.1074/mcp.M114.041335. Epub 2015 Apr 22.

18.

Establishment and characterization of models of chemotherapy resistance in colorectal cancer: Towards a predictive signature of chemoresistance.

Jensen NF, Stenvang J, Beck MK, Hanáková B, Belling KC, Do KN, Viuff B, Nygård SB, Gupta R, Rasmussen MH, Tarpgaard LS, Hansen TP, Budinská E, Pfeiffer P, Bosman F, Tejpar S, Roth A, Delorenzi M, Andersen CL, Rømer MU, Brünner N, Moreira JM.

Mol Oncol. 2015 Jun;9(6):1169-85. doi: 10.1016/j.molonc.2015.02.008. Epub 2015 Feb 24.

19.

IGF2 is an actionable target that identifies a distinct subpopulation of colorectal cancer patients with marginal response to anti-EGFR therapies.

Zanella ER, Galimi F, Sassi F, Migliardi G, Cottino F, Leto SM, Lupo B, Erriquez J, Isella C, Comoglio PM, Medico E, Tejpar S, Budinská E, Trusolino L, Bertotti A.

Sci Transl Med. 2015 Jan 28;7(272):272ra12. doi: 10.1126/scitranslmed.3010445.

20.

The tyrosine phosphatase PTPRO sensitizes colon cancer cells to anti-EGFR therapy through activation of SRC-mediated EGFR signaling.

Asbagh LA, Vazquez I, Vecchione L, Budinska E, De Vriendt V, Baietti MF, Steklov M, Jacobs B, Hoe N, Singh S, Imjeti NS, Zimmermann P, Sablina A, Tejpar S.

Oncotarget. 2014 Oct 30;5(20):10070-83.

21.

Test of four colon cancer risk-scores in formalin fixed paraffin embedded microarray gene expression data.

Di Narzo AF, Tejpar S, Rossi S, Yan P, Popovici V, Wirapati P, Budinska E, Xie T, Estrella H, Pavlicek A, Mao M, Martin E, Scott W, Bosman FT, Roth A, Delorenzi M.

J Natl Cancer Inst. 2014 Sep 22;106(10). pii: dju247. doi: 10.1093/jnci/dju247. Print 2014 Oct.

PMID:
25246611
22.

Patient-derived xenograft models: an emerging platform for translational cancer research.

Hidalgo M, Amant F, Biankin AV, Budinská E, Byrne AT, Caldas C, Clarke RB, de Jong S, Jonkers J, Mælandsmo GM, Roman-Roman S, Seoane J, Trusolino L, Villanueva A.

Cancer Discov. 2014 Sep;4(9):998-1013. doi: 10.1158/2159-8290.CD-14-0001. Epub 2014 Jul 15. Review.

23.

Distal and proximal colon cancers differ in terms of molecular, pathological, and clinical features.

Missiaglia E, Jacobs B, D'Ario G, Di Narzo AF, Soneson C, Budinska E, Popovici V, Vecchione L, Gerster S, Yan P, Roth AD, Klingbiel D, Bosman FT, Delorenzi M, Tejpar S.

Ann Oncol. 2014 Oct;25(10):1995-2001. doi: 10.1093/annonc/mdu275. Epub 2014 Jul 23.

PMID:
25057166
24.

Cross-species analysis of genetically engineered mouse models of MAPK-driven colorectal cancer identifies hallmarks of the human disease.

Belmont PJ, Budinska E, Jiang P, Sinnamon MJ, Coffee E, Roper J, Xie T, Rejto PA, Derkits S, Sansom OJ, Delorenzi M, Tejpar S, Hung KE, Martin ES.

Dis Model Mech. 2014 Jun;7(6):613-23. doi: 10.1242/dmm.013904. Epub 2014 Apr 17.

25.

Context-dependent interpretation of the prognostic value of BRAF and KRAS mutations in colorectal cancer.

Popovici V, Budinska E, Bosman FT, Tejpar S, Roth AD, Delorenzi M.

BMC Cancer. 2013 Sep 27;13:439. doi: 10.1186/1471-2407-13-439.

26.

DUSP 4 expression identifies a subset of colorectal cancer tumors that differ in MAPK activation, regardless of the genotype.

De Vriendt V, De Roock W, Di Narzo AF, Tian S, Biesmans B, Jacobs B, Budinska E, Sagaert X, Rossi S, D'Ario G, Delorenzi M, Simon I, Vecchione L, Tejpar S.

Biomarkers. 2013 Sep;18(6):516-24. doi: 10.3109/1354750X.2013.819038. Epub 2013 Jul 22.

PMID:
23875912
27.

Gene expression patterns unveil a new level of molecular heterogeneity in colorectal cancer.

Budinska E, Popovici V, Tejpar S, D'Ario G, Lapique N, Sikora KO, Di Narzo AF, Yan P, Hodgson JG, Weinrich S, Bosman F, Roth A, Delorenzi M.

J Pathol. 2013 Sep;231(1):63-76. doi: 10.1002/path.4212. Epub 2013 Jul 8.

28.

Molecular heterogeneity and centrosome-associated genes in multiple myeloma.

Kryukov F, Nemec P, Dementyeva E, Kubiczkova L, Ihnatova I, Budinska E, Jarkovsky J, Sevcikova S, Kuglik P, Hajek R.

Leuk Lymphoma. 2013 Sep;54(9):1982-8. doi: 10.3109/10428194.2013.764416. Epub 2013 Feb 18.

PMID:
23323949
29.

[Comparison of laparotomic and laparoscopic techniques for implantation of the peritoneal part of the shunt in the treatment of hydrocephalus].

Vybíhal V, Svoboda T, Procházka V, Benda P, Hanoun G, Smrčka M, Kala Z, Budinská E, Bohatá S.

Rozhl Chir. 2012 Jun;91(6):305-10. Czech.

PMID:
23078222
30.

A comprehensive characterization of genome-wide copy number aberrations in colorectal cancer reveals novel oncogenes and patterns of alterations.

Xie T, D' Ario G, Lamb JR, Martin E, Wang K, Tejpar S, Delorenzi M, Bosman FT, Roth AD, Yan P, Bougel S, Di Narzo AF, Popovici V, Budinská E, Mao M, Weinrich SL, Rejto PA, Hodgson JG.

PLoS One. 2012;7(7):e42001. doi: 10.1371/journal.pone.0042001. Epub 2012 Jul 31.

31.

Breast cancer suppressor candidate-1 (BCSC-1) is a melanoma tumor suppressor that down regulates MITF.

Anghel SI, Correa-Rocha R, Budinska E, Boligan KF, Abraham S, Colombetti S, Fontao L, Mariotti A, Rimoldi D, Ghanem GE, Fisher DE, Lévy F, Delorenzi M, Piguet V.

Pigment Cell Melanoma Res. 2012 Jul;25(4):482-7. doi: 10.1111/j.1755-148X.2012.01018.x. Erratum in: Pigment Cell Melanoma Res. 2012 Nov;25(6):834. Correa-Rochal, Rafael [corrected to Correa-Rocha, Rafael]; Boliganl, Kayluz F [corrected to Boligan, Kayluz F].

PMID:
22594792
32.

Identification of a poor-prognosis BRAF-mutant-like population of patients with colon cancer.

Popovici V, Budinska E, Tejpar S, Weinrich S, Estrella H, Hodgson G, Van Cutsem E, Xie T, Bosman FT, Roth AD, Delorenzi M.

J Clin Oncol. 2012 Apr 20;30(12):1288-95. doi: 10.1200/JCO.2011.39.5814. Epub 2012 Mar 5.

PMID:
22393095
33.

NKT-like cells are expanded in solid tumour patients.

Zdrazilova-Dubska L, Valik D, Budinska E, Frgala T, Bacikova L, Demlova R.

Klin Onkol. 2012;25 Suppl 2:2S21-5.

PMID:
23581012
34.

Rgtsp: a generalized top scoring pairs package for class prediction.

Popovici V, Budinská E, Delorenzi M.

Bioinformatics. 2011 Jun 15;27(12):1729-30. doi: 10.1093/bioinformatics/btr233. Epub 2011 Apr 19.

PMID:
21505033
35.

A distinct expression of various gene subsets in CD34+ cells from patients with early and advanced myelodysplastic syndrome.

Vasikova A, Belickova M, Budinska E, Cermak J.

Leuk Res. 2010 Dec;34(12):1566-72. doi: 10.1016/j.leukres.2010.02.021. Epub 2010 Mar 29.

PMID:
20303173
36.

Unraveling an FNR based regulatory circuit in Paracoccus denitrificans using a proteomics-based approach.

Bouchal P, Struhárová I, Budinská E, Sedo O, Vyhlídalová T, Zdráhal Z, van Spanning R, Kucera I.

Biochim Biophys Acta. 2010 Jun;1804(6):1350-8. doi: 10.1016/j.bbapap.2010.01.016. Epub 2010 Jan 29.

PMID:
20116460
37.

[Profiles of low-molecular proteome spectrum obtained through SELDI-TOF mass spectrometry in the sera of patients with metastatic malignant melanoma: pilot study].

Lakomý R', Greplová K, Pilný R, Budinská E, Valík D, Poprach A, Nemecek R, Vyzula R.

Klin Onkol. 2009;22(5):228-32. Czech.

PMID:
19886361
38.

Bullous pemphigoid and internal diseases - A case-control study.

Jedlickova H, Hlubinka M, Pavlik T, Semradova V, Budinska E, Vlasin Z.

Eur J Dermatol. 2010 Jan-Feb;20(1):96-101. doi: 10.1684/ejd.2010.0805. Epub 2009 Oct 2.

PMID:
19797038
39.

[Functional integrity of neural retina in 2. type diabetics].

Beszédesová N, Budinská E, Skorkovská S.

Cesk Slov Oftalmol. 2009 Jul;65(4):124-30. Slovak.

PMID:
19750829
40.

Differential gene expression of bone marrow CD34+ cells in early and advanced myelodysplastic syndrome.

Vasikova A, Budinska E, Belickova M, Cermak J, Bruchova H.

Neoplasma. 2009;56(4):335-42.

PMID:
19469654
41.

MSMAD: a computationally efficient method for the analysis of noisy array CGH data.

Budinska E, Gelnarova E, Schimek MG.

Bioinformatics. 2009 Mar 15;25(6):703-13. doi: 10.1093/bioinformatics/btp022. Epub 2009 Jan 15.

PMID:
19147666
42.

Surface-enhanced laser desorption/ionization time-of-flight proteomic profiling of breast carcinomas identifies clinicopathologically relevant groups of patients similar to previously defined clusters from cDNA expression.

Brozkova K, Budinska E, Bouchal P, Hernychova L, Knoflickova D, Valik D, Vyzula R, Vojtesek B, Nenutil R.

Breast Cancer Res. 2008;10(3):R48. doi: 10.1186/bcr2101. Epub 2008 May 29.

43.

aro mutations in Salmonella enterica cause defects in cell wall and outer membrane integrity.

Sebkova A, Karasova D, Crhanova M, Budinska E, Rychlik I.

J Bacteriol. 2008 May;190(9):3155-60. doi: 10.1128/JB.00053-08. Epub 2008 Feb 29.

44.

Screening of genomic imbalances in glioblastoma multiforme using high-resolution comparative genomic hybridization.

Vranová V, Necesalová E, Kuglík P, Cejpek P, Pesáková M, Budínská E, Relichová J, Veselská R.

Oncol Rep. 2007 Feb;17(2):457-64.

PMID:
17203188
45.

Identification of putative ancestors of the multidrug-resistant Salmonella enterica serovar typhimurium DT104 clone harboring the Salmonella genomic island 1.

Matiasovicova J, Adams P, Barrow PA, Hradecka H, Malcova M, Karpiskova R, Budinska E, Pilousova L, Rychlik I.

Arch Microbiol. 2007 May;187(5):415-24. Epub 2006 Dec 20.

PMID:
17180672
46.

[DIAGNOSIS AND SURGICAL TREATMENT OF INSUFFICIENCY OF THE CERVIX UTERI IN PREGNANCY].

SNAID V, BUDINSKA E, CERNOCH A, FINKOVA A, GAZAREK F, POKORNY J, RAFFAJ K.

Cesk Gynekol. 1964 May;29:254-8. Czech. No abstract available.

PMID:
14170355

Supplemental Content

Loading ...
Support Center